Wolverine Trading, LLC Cardiff Oncology, Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.05 - $2.77 $30,339 - $40,996
14,800 Added 111.28%
28,100 $75,000
Q2 2024

Aug 14, 2024
BUY
$2.22 - $5.89 $29,526 - $78,337
13,300 New
13,300 $29,000
Q3 2022

Nov 14, 2022
BUY
$1.54 - $3.21 $24,486 - $51,039
15,900 New
15,900 $24,000

Others Institutions Holding CRDF

# of Institutions
90
Shares Held
12.3M
Call Options Held
813K
Put Options Held
91.1K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $110M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email